Search results for: COVID
Millions Face Medicaid Loss When COVID PHE Ends
The COVID Public Health Emergency (PHE) ends in mid-May and could adversely impact healthcare insurance for millions of Americans. The PHE extended Medicaid eligibility allowing millions to receive healthcare insurance. However, a little-publicized change about the PHE ending is that roughly 18 million will lose their Medicaid coverage. As of April 1, 2023, states…
Read MoreLung Abnormalities Continue Even 2 Years After Severe COVID
Two recent studies confirm lung scarring and other abnormalities occur in many COVID patients — even two years later. The studies were conducted at the Margaret Turner Warwick Center for Fibrosing Lung Disease with Iain Stewart, PhD. as corresponding author and at Tongji Medical College of Huazhong University and led by co-senior authors Qing Ye,…
Read MoreCancer Patients Present Imaging Challenges on COVID CT Scans
CT scans are a critical diagnostic tool for diagnosing COVID pneumonia. Given the number of cancer patients and their susceptibility to infections adds to the overall number of COVID cases. In many emergency departments, cancer patients are likely a substantial portion of any COVID-infected population. However, a recent study revealed that cancer patients face…
Read MoreChest CT Scans Reveal Effectiveness of Different COVID Vaccines
Emerging research about the ability of a chest CT scan to differentiate the efficacy of various COVID-19 vaccines could help dispel vaccine hesitancy. A new study, published in the American Journal of Roentgenology, highlights the critical knowledge gained from a retrospective view of chest CT scans of patients who developed COVID pneumonia. The study was…
Read MoreCOVID-Delayed Screenings Increase Late-Stage Breast Cancer Diagnoses
The National Cancer Institute, in June 2020, expressed fears that declines in cancer screenings and delays in treatment due to the COVID-19 pandemic could contribute to an increase in rates of advanced cancer diagnoses and deaths through 2030. A recent study was led by Jade Zifei Zhou, MD, Ph.D., a hematology/oncology fellow at Moores Cancer…
Read More